DEFA4 was observed to be more effective than DEFA1, 2, 3 in protecting peripheral blood mononuclear cells (PBMCs) from infection by both strains of HIV-1 [15], although DEFA4 has a significantly weaker capacity in acting as a lectin ligand to gp120 and CD4. This evidence concerns the gene DEFA4 and infection.